TABLE 4.

Molecular capsular typing and sequence types of the bovine and human resistant isolates.

	Bovine isolates		Human isolates
	MCT	ST	MCT	ST
Erythromycin	Ia	12, 1,366
	Ib	1	Ib	10
	II	591 (2)	II	19, 22, 28
	V	1, 498 (3)	V	1 (7), 19, 109, 498, NT
	NT	2
Kanamycin		All strains		All strains
Pirlimycin	Ib	1	Ib	10
	III	1,397	II	19, 22
	IV	459, 1,363
	V	1 (2), 498	V	1 (7), 19, NT
	NT	2 (2)
Sulfisoxazole	Ia	4, 103 (4), 591, 1002, 1366	Ia	4, 23 (8), 55, 144
			Ib	8, 12
	II	591 (7)	II	10, 12, 19 (2), 22, 28 (4), 932
	III	23 (2)	III	17 (10), 19 (2)
	IV	297 (3), 1363, 1365	IV	196
	V	1	V	1 (2), 19 (2), 26, 498, 832, NT
Tetracycline	Ia	12, 23, 103 (11), 314 (2), 1002 (2)	Ia	23 (4), 24, 498
	Ib	1, 6 (3)	Ib	12
			II	1, 12, 19 (2), 22, 28 (2), 569, 932
	III	27, NT	III	17 (5), 529 (2)
	IV	297, 459, 1363, 1398,	IV	196 (2)
	V	498 (3)	V	1 (4), 19, 26 (2), 498, 529, 832, NT
	NT	2 (2)
Trimethoprim – sulfamethoxazole	V	1

MCT, molecular capsular typing; ST, sequence type.